Loading organizations...
Key people at Guozhong Capital.
Guozhong Capital is a venture capital firm based in Shenzhen, Guangdong, China, investing in innovative small and medium-sized enterprises across technology, biomedical, healthcare, TMT, manufacturing, semiconductors, and medical fields. It manages the 6 billion Yuan National Small Medium Enterprises Development Fund, with its three-member management team holding a 51% stake and Shenzhen Venture Capital Group the remaining 49% of its 100 million Yuan registered capital. Its portfolio features companies like PIX Moving (Series B funding) and Baiwang (IPO July 2024). Empyrean Technology (EDA software) listed on the Growth Enterprise Market in July 2022, achieving a 40.72 billion Yuan market value. Managing Director Wei Jia, Partner Ma Ruopeng, and TMT investment director Yang Yang lead the firm, founded in December 2015.
Key people at Guozhong Capital.
Guozhong Capital has 7 tracked investments across 7 companies. The latest tracked deal is $14.3M Series A in Errui Xinyue in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 26, 2025 | Errui Xinyue | $14.3M Series A | Guozhong Capital | — |
| Dec 8, 2025 | EngineAI Robotics | $141.4M Series A | Huangpu River Capital | Cctv Fund, Fortune Capital, Henan Investment Group, Hunan Caixin Investment Holding Group, Nanshan SEI Investment, Stone Ventures, TH Capital, Welkin, Xingyuan Capital |
| Nov 29, 2023 | Simetric Semiconductor | $14.0M Series A | Guozhong Capital | Zhongxin Chuangtou |
| Nov 1, 2023 | Hydrogen Energy | $13.7M Series A | Guozhong Capital | — |
| Jun 1, 2023 | Aibo Medical Robot | $14.1M Series A | Guozhong Capital | Xiaodong Jiang |
| Oct 12, 2021 | Chance Pharmaceuticals | $30.0M Series C | Zhihua YU | HEDA BioVenture |
| Feb 28, 2020 | Ascentawits | $14.3M Series A | Guozhong Capital | — |
